FDA Asks for Comments on Collection of Import Info at Entry
The Food and Drug Administration is asking for comments by Jan. 27 on its collection of information from import entry documentation. In addition to reviewing information provided to CBP through the Automated Commercial System, FDA also requires importers to declare the FDA Product Code, FDA country of production, manufacturer/shipper, and ultimate consignee, before the agency makes its admissibility decision. FDA says 3,406 respondents report that information each year for non-tobacco shipments, providing 1,089 responses each that take 8 minutes each to compile, for a total of 517,219 burden hours each year.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
FDA is asking for comments on the following (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology.
(Federal Register 11/27/13)